Chalmers AJ - Search Results

1

Targeting PARP for Chemoradiosensitization: Opportunities, Challenges, and the Road Ahead.

Willers H, Krause M, Faivre-Finn C, Chalmers AJ. Willers H, et al. Among authors: chalmers aj. Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):265-270. doi: 10.1016/j.ijrobp.2021.10.142. Int J Radiat Oncol Biol Phys. 2022. PMID: 34998527 Free PMC article. No abstract available.

2

PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation.

Chalmers A, Johnston P, Woodcock M, Joiner M, Marples B. Chalmers A, et al. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):410-9. doi: 10.1016/j.ijrobp.2003.09.053. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751510

3

Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential.

Dungey FA, Löser DA, Chalmers AJ. Dungey FA, et al. Among authors: chalmers aj. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1188-97. doi: 10.1016/j.ijrobp.2008.07.031. Int J Radiat Oncol Biol Phys. 2008. PMID: 18954712

4

The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer.

Harrow S, Hanna GG, Faivre-Finn C, McDonald F, Chalmers AJ. Harrow S, et al. Among authors: chalmers aj. Clin Oncol (R Coll Radiol). 2016 Nov;28(11):720-725. doi: 10.1016/j.clon.2016.08.004. Epub 2016 Aug 31. Clin Oncol (R Coll Radiol). 2016. PMID: 27591000 Free article. Review.

5

Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA, Lievens Y, Sebag-Montefiore D, Coles CE. Thompson MK, et al. Among authors: chalmers aj. Br J Cancer. 2018 Aug;119(4):389-407. doi: 10.1038/s41416-018-0201-z. Epub 2018 Jul 31. Br J Cancer. 2018. PMID: 30061587 Free PMC article. Review.

6

Assembling the brain trust: the multidisciplinary imperative in neuro-oncology.

Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF. Ludmir EB, et al. Among authors: chalmers aj. Nat Rev Clin Oncol. 2019 Aug;16(8):521-522. doi: 10.1038/s41571-019-0235-z. Nat Rev Clin Oncol. 2019. PMID: 31150024 No abstract available.

7

CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.

Walls GM, Oughton JB, Chalmers AJ, Brown S, Collinson F, Forster MD, Franks KN, Gilbert A, Hanna GG, Hannaway N, Harrow S, Haswell T, Hiley CT, Hinsley S, Krebs M, Murden G, Phillip R, Ryan AJ, Salem A, Sebag-Montefoire D, Shaw P, Twelves CJ, Walker K, Young RJ, Faivre-Finn C, Greystoke A. Walls GM, et al. Among authors: chalmers aj. Clin Transl Radiat Oncol. 2020 Sep 22;25:61-66. doi: 10.1016/j.ctro.2020.09.006. eCollection 2020 Nov. Clin Transl Radiat Oncol. 2020. PMID: 33072895 Free PMC article.

8

Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date.

Derby SJ, Chalmers AJ, Carruthers RD. Derby SJ, et al. Among authors: chalmers aj. Semin Radiat Oncol. 2022 Jan;32(1):15-28. doi: 10.1016/j.semradonc.2021.09.005. Semin Radiat Oncol. 2022. PMID: 34861992 Free article. Review.

9

Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE.

Walker K, Hinsley S, Phillip R, Oughton JB, Murden G, Chalmers AJ, Faivre-Finn C, Greystoke A, Brown SR; CONCORDE Investigators. Walker K, et al. Among authors: chalmers aj. JCO Precis Oncol. 2022 Nov;6:e2200133. doi: 10.1200/PO.22.00133. JCO Precis Oncol. 2022. PMID: 36446040 Free PMC article.

10

Poly(ADP-ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets.

Chalmers AJ, Lakshman M, Chan N, Bristow RG. Chalmers AJ, et al. Semin Radiat Oncol. 2010 Oct;20(4):274-81. doi: 10.1016/j.semradonc.2010.06.001. Semin Radiat Oncol. 2010. PMID: 20832020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters